Kardigan KARD
NASDAQ KARD
$13.82 -0.30 (-2.12%)
At close: Nov 13, 2026 · 4:00 PM EST

Kardigan (KARD) Gains (Losses) on Sale of Assets & Investments (2026)

Updated

Kardigan (KARD) posted Gains (Losses) on Sale of Assets & Investments of -$1.87 million for Q3 2026, compared with -$53,000 a year earlier.

Analysis

Kardigan (KARD) Gains (Losses) on Sale of Assets & Investments (2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Gains (Losses) on Sale of Assets & Investments at Kardigan was -$2.05 million; for FY2025, it was $63,000.

  • According to Business Quant data, Gains (Losses) on Sale of Assets & Investments for the three prior quarters was -$145,000 (Q2 2026), -$153,000 (Q1 2026) and $116,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Kardigan 1.29 Bn -398.44 Mn - -1.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -1.87 Mn
Jun 30, 2026 -145,000.00
Mar 31, 2026 -153,000.00
API Access

Kardigan Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=KARD&period=max&api_key=YOUR_API_KEY